LifeStance Health Group, Inc.
LFST
$8.10
$0.172.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.46% | 13.85% | 13.39% | 13.86% | 16.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.46% | 13.85% | 13.39% | 13.86% | 16.31% |
| Cost of Revenue | 16.34% | 13.51% | 11.27% | 10.47% | 11.56% |
| Gross Profit | 16.71% | 14.59% | 18.06% | 21.60% | 27.58% |
| SG&A Expenses | 5.70% | 5.91% | 8.16% | 5.58% | 4.49% |
| Depreciation & Amortization | -12.60% | -22.83% | -28.67% | -30.67% | -25.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.93% | 9.35% | 7.91% | 6.32% | 6.91% |
| Operating Income | 479.60% | 181.87% | 114.24% | 100.95% | 89.06% |
| Income Before Tax | 187.60% | 121.46% | 86.54% | 86.43% | 79.71% |
| Income Tax Expenses | 483.33% | 1,688.24% | -131.55% | 36.73% | 82.97% |
| Earnings from Continuing Operations | 165.09% | 116.82% | 90.43% | 89.30% | 79.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 165.09% | 116.82% | 90.43% | 89.30% | 79.41% |
| EBIT | 479.60% | 181.87% | 114.24% | 100.95% | 89.06% |
| EBITDA | 97.11% | 90.00% | 160.48% | 3,113.06% | 308.34% |
| EPS Basic | 163.79% | 116.40% | 90.65% | 89.53% | 79.98% |
| Normalized Basic EPS | 193.72% | 121.40% | 86.13% | 80.88% | 73.34% |
| EPS Diluted | 159.34% | 114.93% | 90.33% | 88.19% | 78.94% |
| Normalized Diluted EPS | 191.51% | 120.65% | 86.05% | 80.88% | 73.34% |
| Average Basic Shares Outstanding | 1.61% | 1.81% | 2.25% | 2.35% | 2.98% |
| Average Diluted Shares Outstanding | 2.34% | 3.02% | 2.87% | 2.84% | 3.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |